199 related articles for article (PubMed ID: 11182040)
1. Cisplatin-based chemotherapy for postoperative recurrence in non-small cell lung cancer patients: relation of the in vitro chemosensitive test to clinical response.
Higashiyama M; Kodama K; Yokouchi H; Takami K; Nakagawa H; Imamura F; Minamigawa K; Kobayashi H
Oncol Rep; 2001; 8(2):279-83. PubMed ID: 11182040
[TBL] [Abstract][Full Text] [Related]
2. Prediction of chemotherapeutic effect on postoperative recurrence by in vitro anticancer drug sensitivity testing in non-small cell lung cancer patients.
Higashiyama M; Oda K; Okami J; Maeda J; Kodama K; Imamura F; Minamikawa K; Takano T; Kobayashi H
Lung Cancer; 2010 Jun; 68(3):472-7. PubMed ID: 19660825
[TBL] [Abstract][Full Text] [Related]
3. Collagen gel droplet-embedded culture drug sensitivity test for adjuvant chemotherapy after complete resection of non-small-cell lung cancer.
Inoue M; Maeda H; Takeuchi Y; Fukuhara K; Shintani Y; Funakoshi Y; Funaki S; Nojiri T; Kusu T; Kusumoto H; Kimura T; Okumura M;
Surg Today; 2018 Apr; 48(4):380-387. PubMed ID: 28993901
[TBL] [Abstract][Full Text] [Related]
4. Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: comparison of non-small cell lung cancer and small cell lung cancer.
Shaw GL; Gazdar AF; Phelps R; Steinberg SM; Linnoila RI; Johnson BE; Oie HK; Russell EK; Ghosh BC; Pass HI; Minna JD; Mulshine JL; Ihde DC
J Cell Biochem Suppl; 1996; 24():173-85. PubMed ID: 8806100
[TBL] [Abstract][Full Text] [Related]
5. Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing.
Shaw GL; Gazdar AF; Phelps R; Linnoila RI; Ihde DC; Johnson BE; Oie HK; Pass HI; Steinberg SM; Ghosh BC
Cancer Res; 1993 Nov; 53(21):5181-7. PubMed ID: 8221655
[TBL] [Abstract][Full Text] [Related]
6. In vitro-chemosensitivity test using the collagen gel droplet embedded culture drug test (CD-DST) for malignant pleural mesothelioma: possibility of clinical application.
Higashiyama M; Oda K; Okami J; Maeda J; Kodama K; Takami K; Morinaga K; Takano T; Kobayashi H
Ann Thorac Cardiovasc Surg; 2008 Dec; 14(6):355-62. PubMed ID: 19131921
[TBL] [Abstract][Full Text] [Related]
7. Postoperative adjuvant chemotherapy with PVM (Cisplatin + Vindesine + Mitomycin C) and UFT (Uracil + Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. West Japan Study Group for lung cancer surgery (WJSG).
Wada H; Miyahara R; Tanaka F; Hitomi S
Eur J Cardiothorac Surg; 1999 Apr; 15(4):438-43. PubMed ID: 10371118
[TBL] [Abstract][Full Text] [Related]
8. Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study.
Jelić S; Mitrović L; Radosavljević D; Elezar E; Babović N; Kovcin V; Tomasević Z; Kovacević S; Gavrilović D; Radulović S
Lung Cancer; 2001 Oct; 34(1):1-13. PubMed ID: 11557107
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical p53 protein status in nonsmall cell lung cancer is a promising indicator in determining in vitro chemosensitivity to some anticancer drugs.
Higashiyama M; Kodama K; Yokouchi H; Takami K; Doi O; Kobayashi H; Tanisaka K; Minamigawa K
J Surg Oncol; 1998 May; 68(1):19-24. PubMed ID: 9610658
[TBL] [Abstract][Full Text] [Related]
10. Clinical responses of large cell neuroendocrine carcinoma of the lung to cisplatin-based chemotherapy.
Yamazaki S; Sekine I; Matsuno Y; Takei H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T; Kodama T; Asamura H; Tsuchiya R; Saijo N
Lung Cancer; 2005 Aug; 49(2):217-23. PubMed ID: 16022916
[TBL] [Abstract][Full Text] [Related]
11. [Radio-chemotherapy combination in locally advanced, inoperable, non-small cell bronchial cancers].
Mornex F
Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S37-41. PubMed ID: 12538934
[No Abstract] [Full Text] [Related]
12. Adjuvant chemotherapy in resected non-small cell lung cancer.
Cangiano R
Rays; 2004; 29(4):435-7. PubMed ID: 15852732
[TBL] [Abstract][Full Text] [Related]
13. A randomized Phase 2 study of pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in patients with completely resected stage IB or II Non-Small-Cell Lung Cancer.
Schmid-Bindert G; Engel-Riedel W; Reck M; Schuette W; Stöhlmacher J; Fischer JR; Mazières J; Chouaid C; Wolf M; Vinolas N; Soldatenkova V; Ripoche V; Nguyen T; Visseren-Grul C
Lung Cancer; 2015 Dec; 90(3):397-404. PubMed ID: 26791798
[TBL] [Abstract][Full Text] [Related]
14. Non small cell lung cancer treatment with carboplatin and vindesine: a phase II study.
Bretti S; Bonardi GM; Celano A; Comandone A; Casadio C; Marchisio U; Forconi G; Manzoni S; Bumma C
Anticancer Res; 1992; 12(5):1459-61. PubMed ID: 1332578
[TBL] [Abstract][Full Text] [Related]
15. [Postoperative adjuvant chemotherapy for non-small cell lung cancer].
Okamoto T; Ichinose Y
Gan To Kagaku Ryoho; 2005 Jun; 32(6):765-9. PubMed ID: 15984513
[TBL] [Abstract][Full Text] [Related]
16. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer.
Scagliotti GV; Fossati R; Torri V; Crinò L; Giaccone G; Silvano G; Martelli M; Clerici M; Cognetti F; Tonato M;
J Natl Cancer Inst; 2003 Oct; 95(19):1453-61. PubMed ID: 14519751
[TBL] [Abstract][Full Text] [Related]
17. [Current data concerning neoadjuvant chemotherapy].
Depierre A
Rev Pneumol Clin; 2006 Feb; 62 Spec no 1():1S11-3. PubMed ID: 16719148
[No Abstract] [Full Text] [Related]
18. [A pilot study of induction chemotherapy with cisplatin, mitomycin C and vindesine for stage III N2 non-small cell lung cancer].
Nishiwaki Y; Nagai K; Kodama T; Nishiyama H; Hojo H; Matsumoto T
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():203-11. PubMed ID: 8007467
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of adjuvant carboplatin-based chemotherapy compared to cisplatin in non-small cell lung cancer.
Couillard-Montminy V; Gagnon PY; Fortin S; Côté J
J Oncol Pharm Pract; 2019 Jan; 25(1):44-51. PubMed ID: 28825377
[TBL] [Abstract][Full Text] [Related]
20. A retrospective comparison of adjuvant chemotherapeutic regimens for non-small cell lung cancer (NSCLC): paclitaxel plus carboplatin versus vinorelbine plus cisplatin.
Chang WJ; Sun JM; Lee JY; Ahn JS; Ahn MJ; Park K
Lung Cancer; 2014 Apr; 84(1):51-5. PubMed ID: 24521819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]